Hutch News

Hutch News

Stories tagged 'Hans-Peter Kiem'

Gene editing shows promise for sickle cell and related disorders

Preclinical results offer new hope in group of dangerous inborn diseases

May 23, 2018 | By Susan Keown / Fred Hutch News Service

New research, not yet in humans, suggests that a novel gene-editing strategy holds promise for people with sickle cell disease and other serious inborn disorders of hemoglobin.

View story >


Dr. Reema Jain developing methods to isolate, manipulate blood stem cells for T-cell therapy

Funding from Immunotherapy Integrated Research Center supports postdoc’s work

May 1, 2018 | By Susan Keown / Fred Hutch News Service

Dr. Reema Jain has received salary and research support from the Fred Hutch Immunotherapy Integrated Research Center.

View story >


Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals

April 25, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch study shows gene editing holds promise for shrinking HIV "reservoir" — a key step toward driving the virus into remission without the need for antivirals.

View story >


A voice for HIV cure

As researchers work toward a cure, advocate Tranisha Arzah keeps the focus on community

Nov. 29, 2017 | By Mary Engel / Fred Hutch News Service

Born with HIV, Tranisha Arzah joined the community advisory board for the Fred Hutch-based cure research group defeatHIV to "see if I could get other women involved and make sure they have a voice.”

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


New nanoparticles make targeted, temporary gene therapy possible

‘Hit-and-run’ technology could improve immunotherapy and HIV cure research

Aug. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

'Hit-and-run' technology could improve immunotherapy and HIV cure research

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.